The role of surgery in cancer of the stomach

Gastrointestinal Oncology: Evidence and Analysis

Volumn , Issue , 2016, Pages 73-84

  Misra, Nikhil ^a   Hardwick, R ^a   McCulloch, Peter ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878334129     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (85)

1. Coleman MP, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Scientific Publications. Vol. 121, Lyon: IARC Scientific Publications, 1993.
2. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophago-gastric junction. Br J Surg 1998; 85:1457-1459.
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5. Version 2.0. Lyon: IARC Press, 2004.
4. Newnham A, Quinn MJ, Babb P, Kang JY, Majeed A. Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998. Aliment Pharmacol Ther 2003; 17:665-676.
5. Devessa SS, Blot DJ, Fraumeni JF Jr. Changing patterns in the incidence of oesophageal and gastric carcinoma in the United States. Cancer 1998; 83:2049-2053.
6. Forman D. Counting cancers at the junction-a problem of routine statistics. Eur J Gastroenterol Hepatol 2002; 14(2):99-101.
7. Blaser MJ, Saito D. Trends in reported adenocarcinomas of the oesophagus and gastric cardia in Japan. Eur J Gastroenterol Hepatol 2002; 14:107-113.
8. Correa P, Chan VW. Gastric cancer. Cancer Sur 1994; 20:55-76.
9. You WZ, Zhao L, Chang YS, Blot DJ, Fraumeni JF Jr. Progression of precancerous gastric lesions. Lancet 1995; 345:866.
10. Lauren P. The two histological main types of gastric carcinoma; diffuse and so called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64:31-49.
11. Murakami T. Pathomorphological diagnosis. Definition and gross classification in early gastric cancer. GANN Mono 1971; 11:53-55.
12. Kim JP, Hur YS, Yang HK. Lymph node metastases as a significant prognostic factor in early gastric cancer; analysis of 1136 early gastric cancers. Ann Sur Oncol 1995; 2(4):308-313.
13. Saragoni L, Gaudio M, Vio A, Folli S, Nanni O, Saragoni A. Early gastric cancer in the province of Forli: follow up of 337 patients in a high risk region for gastric cancer. Oncol Rep 1998; 5(4):945-948.
14. Tsuchiya A, Kikuchi Y, Ando Y, Yoshida T, Abe R. Lymph node metastases in gastric cancer invading the submucosal layer. Eur J Surg Oncol 1995; 21(3):248-250.
15. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989; 210:596-602.
16. Averbach AM, Jaquet P. Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996; 83:726-733.
17. Sobin LH, Wittekind CH. TNM classification of malignant tumours, 6th ed. New York: Wiley, 2003.
18. Ichikura T, Ogawa T, Chochi K, Kawabata T, Sugasawa H, Mochizuki H. Minimum number of lymph nodes that should be examined for the UICC/AJCC TNM classification of gastric carcinoma. World J Surg 2003; 27:330-333.
19. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 2nd English ed. Gastric Cancer 1998; 1:10-24.
20. Fujii K, Isozaki H, Okajima K, et al. Clinical evaluation of lymph node metastases in gastric cancer as defined by the 5th TNM edition in comparison with the Japanese system. Br J Surg 1999; 86:685-689.
21. D'Ugo D, Pacelli F, Persiani R, et al. Impact of the latest TNM classification of gastric cancer: retrospective analysis of 94 D2 gastrectomies. World J Surg 2002; 26:672-677.
22. Adachi Y, Shiraishi N, Suematsu T, Shiromizu A, Yamaguchi K, Kitano S. Most important lymph node information in gastric cancer; multivariate prognostic study. Ann Surg Oncol 2000; 7:503-507.
23. Adachi Y, Sakino I, Matsumata T, et al. Preoperative assessment of advanced gastric carcinoma using computed tomography. Am J Gastroenterol 1997; 92:872-875.
24. D'Elia F, Zingarelli A, Palli D, Grani M. Hydro-dynamic CT preoperative staging of gastric cancer:correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 2000; 10:1877-1885.
25. Wakelin SJ, Deans C, Crofts TJ, Allan PL, Plevris JN, Paterson-Brown S. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol 2002; 41:161-167.
26. Dittler HJ, Siewert JR. Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy 1993; 25(2):162-166.
27. Smith JW, Brennan MF, Botet JF, Gerdes H, Lightdale CJ. Preoperative endoscopic ultrasound can predict the risk of recurrence after operation for gastric carcinoma. J Clin Oncol 1993; 11(12):2380-2385.
28. Massari M, Cioffi U, De Simone M, et al. Endoscopic ultrasonography for preoperative staging of gastric carcinoma. Hepatogastroenterology 1996; 43(9):542-546.
29. Hunerbein M, Ghadimi BM, Haensch W, Schlag PM. Transendoscopic ultrasound of esophageal and gastric cancer using miniaturized ultrasound catheter probes. Gastrointest Endosc 1998; 48(4):371-375.
30. Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49(4):534-539.
31. Nakamoto Y, Higashi T, Sakahara H, et al. Contribution of PET in the detection of liver metastases from pancreatic tumours. Clin Radiol 1999; 54:248-252.
32. Rasanen JV, Sihvo EI, Knuuti MJ, et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003; 10:954-960.
33. Zhuang H, Sinha P, Pourdehnad M, Duarte PS, Yamamoto AJ, Alavi A. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun 2000; 21:793-798.
34. Possik RA, Franco EL, Pires DR, Wohnrath DR, Ferreira EB. Sensitivity, specificity, and predictive value of laparoscopy for the staging of gastric cancer and for the detection of liver metastases. Cancer 1986; 58(1):1-6.
35. D'Ugo DM, Persiani R, Caracciolo F, Ronconi P, Coco C, Picciocchi A. Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy. Surg Endosc 1997; 11:1159-1162.
36. Lavonius MI, Gullichsen R, Salo S, Sonninen P, Ovaska J. Staging of gastric cancer: a study with spiral computed tomography, ultrasonography, laparoscopy, and laparoscopic ultrasonography. Surg Laparosc Endosc Percutan Tech 2002; 12:77-81.
37. McCulloch P, Johnson M, Jairam R, Fischer W. Laparoscopic staging of gastric cancer is safe and affects treatment strategy. Ann R Coll Surg Engl 1998; 80:400-402.
38. O'Brien MG, Fitzgerald EF, Lee G, Crowley M, Shanahan F, O'Sullivan GC. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery. Am J Gastroenterol 1995; 90:2191-2194.
39. Blackshaw GR, Barry JD, Edwards P, Allison MC, Thomas GV, Lewis WG. Laparoscopy significantly improves the perceived preoperative stage of gastric cancer. Gastric Cancer 2003; 6(4):225-229.
40. Sotiropoulos GC, Kaiser GM, Lang H, et al. Staging laparoscopy in gastric cancer. Eur J Med Res 2005; 10:88-91.
41. Ozmen MM, Zulfikaroglu B, Ozalp N, Ziraman I, Hengirmen S, Sahin B. Staging laparoscopy for gastric cancer. Surg Laparosc Endosc Percutan Tech 2003; 13:241-244.
42. Bryan RT, Cruickshank NR, Needham SJ, et al. Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer. Eur J Surg Oncol 2001; 27:291-297.
43. Hayes N, Wayman J, Wadehra V, Scott DJ, Raimes SA, Griffin SM. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer 1999; 79:520-524.
44. Ribeiro U Jr, Gama-Rodrigues JJ, Bitelman B, et al. Value of peritoneal lavage cytology during laparoscopic staging of patients with gastric carcinoma. Surg Laparosc Endosc 1998; 8:132-135.
45. Ribeiro U Jr, Safatle-Ribeiro AV, Zilberstein B, et al. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg 2006; 10(2):170-176.
46. de Manzoni G, Verlato G, Di Leo A, et al. Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg 2006; 30(4):579-584.
47. McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastro-oesophageal cancer surgery:initial results of ASCOT multicentre prospective cohort study. BMJ 2003; 327:1192-1197.
48. Tekkis PP, McCulloch P, Polonieoki J, et al. Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM. Br J Surg 2004; 91:288-295.
49. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845-850.
50. Prause G, Ratzenhofer-Comenda B, Pierer G, Smolle-Juttner F, Glanzer H, Smolle J. Can ASA grade or Goldman's Cardiac Risk Index predict peri-operative mortality? A study of 16,227 patients. Anaesthesia 1997; 52:203-206.
51. White GH, Advani SM, Williams RA, Wilson SE. Cardiac risk index as a predictor of long-term survival after repair of abdominal aortic aneurysm. Am J Surg 1988; 156:103-107.
52. Zeldin RA. Assessing cardiac risk in patients who undergo noncardiac surgical procedures. Can J Surg 1984; 27:402-404.
53. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85:840-844.
54. Makuuchi H, Kise Y, Shimada H, Chino O, Tanaka H. Endoscopic mucosal resection for early gastric cancer. Semin Surg Oncol 1999; 17(2):108-116.
55. Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48(2):151-152.
56. Miyata M, Yokoyama Y, Okoyama N, et al. What are the appropriate indications for endoscopic mucosal resection for early gastric cancer? Analysis of 256 endoscopically resected lesions. Endoscopy 2000; 32(10):773-778.
57. Wang YP, Bennett C, Pan T. Endoscopic mucosal resection for early gastric cancer. Cochrane Database Syst Rev 2006; 1:CD004276.
58. Uedo N, Iishi H, Tatsuta M, et al. Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer 2006; 9(2):88-92.
59. Imada T, Rino Y, Takahashi M, et al. Gastric emptying after pylorus-preserving gastrectomy in comparison with conventional subtotal gastrectomy for early gastric carcinoma. Surg Today 1998; 28:135-138.
60. Kodama M, Koyama K. Indications for pylorus preserving gastrectomy for early gastric cancer located in the middle third of the stomach. World J Surg 1991; 15:628-633.
61. Shibata C, Shiiba KI, Funayama Y, et al. Outcomes after pylorus-preserving gastrectomy for early gastric cancer: a prospective multicenter trial. World J Surg 2004; 28:857-861.
62. Takahashi S, Maeta M, Mizusawa K, et al. Long-term postoperative analysis of nutritional status after limited gastrectomy for early gastric cancer. Hepatogastroenterology 1998; 45:889-894.
63. Thomas GI, Merendino KA. Jejunal interposition operation; analysis of thirty-three clinical cases. J Am Med Assoc 1958; 168:1759-1766.
64. Katai H, Sano T, Fukagawa T, Shinohara H, Sasako M. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 2003; 90:850-853.
65. Lee SI, Choi YS, Park DJ, Kim HH, Yang HK, Kim MC. Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg 2006; 202(6):874-880.
66. Miura S, Kodera Y, Fujiwara M, et al. Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg 2004; 198(6):933-938.
67. Adachi Y, Shiraishi N, Shiromizu A, Bandoh T, Aramaki M, Kitano S. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy. Arch Surg 2000; 135(7):806-810.
68. Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 2005; 241(2):232-237.
69. Sue-Ling HM, Johnston D, Martin IG, et al. Gastric cancer: a curable disease in Britain. Br Med J 1993; 71:2918-2925.
70. Roukos D, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long term follow up study. Surgery 1998; 123:573-578.
71. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11:418-425.
72. Roder JD, Bonenkamp JJ, Craven J, et al. Lymphadenectomy for gastric cancer in clinical trials: update. World J Surg 1995; 19:546-553.
73. Bachmann MO, Alderson D, Edwards D, et al. Cohort study in south and west England of the influence of specialisation on the management and outcome of patients with oesophageal and gastric cancer. Br J Surg 2002; 89:914-922.
74. Sano T, Katai H, Sasako M, Maruyama K. One thousand consecutive gastrectomies without operative mortality. Br J Surg 2002; 89(1):123.
75. McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004; 4:CD001964.
76. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347:995-999.
77. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer surgery: long term results of the MRC randomized surgical trial. Br J Cancer 2000; 79:1522-1530.
78. Bonenkamp JJ, Songun I, Hermans J, et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745-748.
79. Bonenkamp JJ, Hermans J, Sasako M, et al. Dutch Gastric Cancer Group. Extended lymph node dissection for gastric cancer. N Engl J Med 1999; 340:908-958.
80. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer:who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22(11):2069-2077.
81. Degiuli M, Sasako M, Calgaro M, et al. Italian Gastric Cancer Study Group. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004; 30(3):303-308.
82. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004; 91(3):283-287.
83. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22(14):2767-2773.
84. Kaw M, Singh S, Gagneja H, Azad P. Role of self-expandable metal stents in the palliation of malignant duodenal obstruction. Surg Endosc 2003; 17(4):646-650.
85. Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 2004; 24(1):269-271.